3rd Quarter - Report
NVG, LLC for BIOGEN
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
General issues relating to trade
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Copyright/Patent/Trademark CPT
General issues related to intellectual property and potential changes to the patent system
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE New | — |
Health Issues HCR
supply chain integrity (H.R. 3204 Drug Quality and Security Act and S. 959 Pharmaceutical Quality, Security, and Accountability Act); follow on biologics implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
| ANDREA LARUE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.